[
    [
        {
            "time": "2019-05-16",
            "original_text": "A股共发生59宗大宗交易成交13.66亿元（5月16日）",
            "features": {
                "keywords": [
                    "大宗交易",
                    "A股",
                    "成交额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股共发生59宗大宗交易成交13.66亿元（5月16日）",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-05-16",
            "original_text": "上海证券市场大宗交易公开信息(2019-05-16)",
            "features": {
                "keywords": [
                    "上海证券市场",
                    "大宗交易",
                    "公开信息"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海证券市场大宗交易公开信息(2019-05-16)",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-05-16",
            "original_text": "益丰药房今日大宗交易成交373.90万股，成交价58.39元折价10.03%",
            "features": {
                "keywords": [
                    "益丰药房",
                    "大宗交易",
                    "折价"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "益丰药房今日大宗交易成交373.90万股，成交价58.39元折价10.03%",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-05-16",
            "original_text": "益丰药房控股股东减持股份结果的公告",
            "features": {
                "keywords": [
                    "益丰药房",
                    "控股股东",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "益丰药房控股股东减持股份结果的公告",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-05-16",
            "original_text": "益丰药房(603939.SH)控股股东及其一致行动人合计减持2.98%公司股份 减持股份",
            "features": {
                "keywords": [
                    "益丰药房",
                    "控股股东",
                    "一致行动人",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "益丰药房(603939.SH)控股股东及其一致行动人合计减持2.98%公司股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-05-16",
            "original_text": "益丰药房：控股股东及其一致行动人减持计划完成，共减持2.98%股份 减持股份",
            "features": {
                "keywords": [
                    "益丰药房",
                    "控股股东",
                    "一致行动人",
                    "减持计划完成"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "益丰药房：控股股东及其一致行动人减持计划完成，共减持2.98%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-06-30",
            "original_text": "量化｜三只非银股有望调入上证50：2019年年中主要宽基指数样本股调整预测",
            "features": {
                "keywords": [
                    "非银股",
                    "上证50",
                    "样本股调整",
                    "量化"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "非银金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "量化｜三只非银股有望调入上证50：2019年年中主要宽基指数样本股调整预测",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-30",
            "original_text": "医药生物行业2018年报&2019一季报业绩回顾:行业整体趋势向上,个股分化加剧",
            "features": {
                "keywords": [
                    "医药生物",
                    "年报",
                    "一季报",
                    "业绩回顾",
                    "行业趋势向上",
                    "个股分化"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2018年报&2019一季报业绩回顾:行业整体趋势向上,个股分化加剧",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]